Amicus Therapeutics
Mark Harnett is a Senior Commercial Operations Analyst at Amicus Therapeutics since July 2018, bringing extensive experience from previous roles at Johnson & Johnson from June 2009 to July 2018, where responsibilities included Data Lead for multiple regions, Senior Commercial Analyst, Business and Tenders Lead, and Compliance Lead. Mark Harnett holds a 2.1 degree in Psychology from the University of the West of England, completed between 2002 and 2005, and attended Lord Wandsworth College from 1993 to 2000.
This person is not in any offices
Amicus Therapeutics
4 followers
Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.